As of Jun 15
| +0.35 / +2.17%|
The 4 analysts offering 12-month price forecasts for Meridian Bioscience Inc have a median target of 15.50, with a high estimate of 17.00 and a low estimate of 11.00. The median estimate represents a -5.78% decrease from the last price of 16.45.
The current consensus among 6 polled investment analysts is to Hold stock in Meridian Bioscience Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.